Genome-wide association meta-analysis of age at first cannabis use
- PMID: 30003630
- PMCID: PMC7087375
- DOI: 10.1111/add.14368
Genome-wide association meta-analysis of age at first cannabis use
Abstract
Background and aims: Cannabis is one of the most commonly used substances among adolescents and young adults. Earlier age at cannabis initiation is linked to adverse life outcomes, including multi-substance use and dependence. This study estimated the heritability of age at first cannabis use and identified associations with genetic variants.
Methods: A twin-based heritability analysis using 8055 twins from three cohorts was performed. We then carried out a genome-wide association meta-analysis of age at first cannabis use in a discovery sample of 24 953 individuals from nine European, North American and Australian cohorts, and a replication sample of 3735 individuals.
Results: The twin-based heritability for age at first cannabis use was 38% [95% confidence interval (CI) = 19-60%]. Shared and unique environmental factors explained 39% (95% CI = 20-56%) and 22% (95% CI = 16-29%). The genome-wide association meta-analysis identified five single nucleotide polymorphisms (SNPs) on chromosome 16 within the calcium-transporting ATPase gene (ATP2C2) at P < 5E-08. All five SNPs are in high linkage disequilibrium (LD) (r2 > 0.8), with the strongest association at the intronic variant rs1574587 (P = 4.09E-09). Gene-based tests of association identified the ATP2C2 gene on 16q24.1 (P = 1.33e-06). Although the five SNPs and ATP2C2 did not replicate, ATP2C2 has been associated with cocaine dependence in a previous study. ATP2B2, which is a member of the same calcium signalling pathway, has been associated previously with opioid dependence. SNP-based heritability for age at first cannabis use was non-significant.
Conclusion: Age at cannabis initiation appears to be moderately heritable in western countries, and individual differences in onset can be explained by separate but correlated genetic liabilities. The significant association between age of initiation and ATP2C2 is consistent with the role of calcium signalling mechanisms in substance use disorders.
Keywords: ATP2C2; Age at first use; cannabis initiation; genome-wide association; heritability; substance use.
© 2018 Society for the Study of Addiction.
Figures
References
-
- Substance Abuse and Mental Health Services Administration. Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2014.
-
- World Health Organisation. Facts & Figures 2016 [cited 2016 November 24]. Available from: http://www.who.int/substance_abuse/facts/cannabis/en/.
-
- Degenhardt L, Lynskey M, Hall W. Cohort trends in the age of initiation of drug use in Australia. Australian and New Zealand journal of public health. 2000;24(4):421–6. - PubMed
-
- Monshouwer K, Smit F, De Graaf R, Van Os J, Vollebergh W. First cannabis use: does onset shift to younger ages? Findings from 1988 to 2003 from the Dutch National School Survey on Substance Use. Addiction. 2005;100(7):963–70. - PubMed
-
- Kokkevi A, Nic Gabhainn S, Spyropoulou M. Early initiation of cannabis use: a cross-national European perspective. The Journal of adolescent health : official publication of the Society for Adolescent Medicine. 2006;39(5):712–9. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- N01 HG065403/HG/NHGRI NIH HHS/United States
- R01 AA009203/AA/NIAAA NIH HHS/United States
- R01 DA018267/DA/NIDA NIH HHS/United States
- DA-018673/DA/NIDA NIH HHS/United States
- R01 AA012502/AA/NIAAA NIH HHS/United States
- R01 DA018673/DA/NIDA NIH HHS/United States
- U01 MH094432/MH/NIMH NIH HHS/United States
- R01 DA018660/DA/NIDA NIH HHS/United States
- RC2 MH089951/MH/NIMH NIH HHS/United States
- RC2 DA028909/DA/NIDA NIH HHS/United States
- R01 AA007535/AA/NIAAA NIH HHS/United States
- R01 DA035804/DA/NIDA NIH HHS/United States
- R01 AA014041/AA/NIAAA NIH HHS/United States
- R01 MH081802/MH/NIMH NIH HHS/United States
- K05 AA017688/AA/NIAAA NIH HHS/United States
- R01 DA012690/DA/NIDA NIH HHS/United States
- RC2 MH089995/MH/NIMH NIH HHS/United States
- R01 DA012849/DA/NIDA NIH HHS/United States
- P50 AA011998/AA/NIAAA NIH HHS/United States
- Foundation Volksbond Rotterdam/International
- R01 AA007728/AA/NIAAA NIH HHS/United States
- MC_UU_12013/6/MRC_/Medical Research Council/United Kingdom
- R01 DA023668/DA/NIDA NIH HHS/United States
- R01 DA021905/DA/NIDA NIH HHS/United States
- R01 DA021913/DA/NIDA NIH HHS/United States
- MC_UU_00011/7/MRC_/Medical Research Council/United Kingdom
- R01 HD042157/HD/NICHD NIH HHS/United States
- MC_UU_00011/1/MRC_/Medical Research Council/United Kingdom
- R56 DA012854/DA/NIDA NIH HHS/United States
- T32 AA007580/AA/NIAAA NIH HHS/United States
- R37 DA018673/DA/NIDA NIH HHS/United States
- R01 AA013321/AA/NIAAA NIH HHS/United States
- R01 DA018432/DA/NIDA NIH HHS/United States
- MR/K023233/1/MRC_/Medical Research Council/United Kingdom
- K02 AA018755/AA/NIAAA NIH HHS/United States
- R01 DA012845/DA/NIDA NIH HHS/United States
- U24 MH068457/MH/NIMH NIH HHS/United States
- R01 AA011330/AA/NIAAA NIH HHS/United States
- R01 DA012854/DA/NIDA NIH HHS/United States
- K05 AA000145/AA/NIAAA NIH HHS/United States
- R01 AA017535/AA/NIAAA NIH HHS/United States
- NARSAD Young Investigator Grant/Brain & Behavior Research Foundation/International
- G0802736/MRC_/Medical Research Council/United Kingdom
- R00 DA023549/DA/NIDA NIH HHS/United States
- K08 DA019951/DA/NIDA NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- R01 AA015416/AA/NIAAA NIH HHS/United States
- R37 AA007728/AA/NIAAA NIH HHS/United States
- MR/L022206/1/MRC_/Medical Research Council/United Kingdom
- R00DA023549/US National Institutes of Health, National Institute on Drug Abuse/International
- NWO 480-05-003/NWO/International
- ERC-284167/ERC_/European Research Council/International
- G0800612/MRC_/Medical Research Council/United Kingdom
- R01 AA013320/AA/NIAAA NIH HHS/United States
- P60 DA011015/DA/NIDA NIH HHS/United States
- R37 AA012502/AA/NIAAA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
